ArticleInternational journal of oncology2020

HSulf‑1 and palbociclib exert synergistic antitumor effects on RB‑positive triple‑negative breast cancer.

Fengxia Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.